Longitudinal Brain Atrophy Patterns in Early <scp>MOG</scp> ‐Antibody Associated Disease and Relapsing Multiple Sclerosis
To our knowledge, this is the first MRI study demonstrating no evidence of regional brain volume loss over time in patients with myelin oligodendrocyte glycoprotein antibody-associated disease using voxel-based morphometry, suggesting a different-probably not progressive-pathophysiological background compared to relapsing multiple sclerosis.
Authors
- Carsten Lukas (ORCID: https://orcid.org/0000-0002-8562-9697)
- Carolin Schwake (ORCID: https://orcid.org/0000-0003-3669-7244)
- Theodoros Ladopoulos (ORCID: https://orcid.org/0009-0006-1735-4130)
- Ruth Schneider (ORCID: https://orcid.org/0000-0002-0997-2725)
- Ann‐Kathrin Kogel (ORCID: https://orcid.org/0000-0002-8217-6063)
- Ralf Gold (ORCID: https://orcid.org/0000-0002-7223-3052)
- Zainab Abbas (ORCID: https://orcid.org/0000-0002-2948-7401)
- Ilya Ayzenberg
- Barbara Bellenberg (ORCID: https://orcid.org/0000-0001-7484-6787)
- Britta Krieger (ORCID: https://orcid.org/0000-0002-6364-2743)
- David Bratek
Institutions
- St. Josef-Hospital (DE)
- Ruhr University Bochum (DE)
Publication Details
- Journal
- European Journal of Neurology
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1111/ene.70354
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bundesministerium für Bildung und Forschung